FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy Orthopedic Use of BPC 157 Sports Med Review The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
fda bpc-157 category 2 bulk drug substances list The FDA just announced that they're taking steps to lift restrictions on 12 peptides — including BPC-157 and TB-500 — making them accessible through compounding pharmacies again. This is a HUGE step